Guardant Health Stock Today
| GH Stock | USD 18.10 0.76 4.38% |
Performance0 of 100
| Odds Of DistressOver 57
|
Guardant Health is trading at 18.10 as of the 25th of April 2024. This is a 4.38 percent increase since the beginning of the trading day. The stock's open price was 17.34. Guardant Health has over 57 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. Equity ratings for Guardant Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of May 2022 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 4th of October 2018 | Category Healthcare | Classification Health Care |
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company was incorporated in 2011 and is headquartered in Redwood City, California. Guardant Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 121.71 M outstanding shares of which 7.64 M shares are currently sold short in the market by investors with about 4.1 days to cover all shorted shares. More on Guardant Health
Moving against Guardant Stock
| 0.84 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
| 0.81 | CAT | Caterpillar Earnings Call Today | PairCorr |
| 0.78 | XOM | Exxon Mobil Corp Earnings Call Tomorrow | PairCorr |
| 0.75 | AXP | American Express Financial Report 19th of July 2024 | PairCorr |
| 0.75 | BAC | Bank of America Sell-off Trend | PairCorr |
| 0.72 | CICHF | China Construction Bank | PairCorr |
| 0.71 | JPM | JPMorgan Chase Financial Report 12th of July 2024 | PairCorr |
Guardant Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Guardant Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Guardant Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CoCEO CoFounder | Helmy Eltoukhy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Healthcare (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Biotechnology, NASDAQ Health Care, Healthcare, Health Care, Health Care Providers & Services, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Guardant Health report their recommendations after researching Guardant Health's financial statements, talking to executives and customers, or listening in on Guardant Health's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Guardant Health. The Guardant consensus assessment is calculated by taking the average forecast from all of the analysts covering Guardant Health. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators obtained from Guardant Health's historical financial statements, Guardant Health is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Guardant Health is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Guardant Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Guardant Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Guardant Health's financial leverage. It provides some insight into what part of Guardant Health's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Guardant Health (GH) is traded on NASDAQ Exchange in USA. It is located in 3100 Hanover Street, Palo Alto, CA, United States, 94304 and employs 1,768 people. Guardant Health is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a market capitalization of 2.11 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Guardant Health's market, we take the total number of its shares issued and multiply it by Guardant Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Guardant Health is active under Health Care Providers & Services sector as part of Health Care industry. The entity has 121.71 M outstanding shares of which 7.64 M shares are currently sold short in the market by investors with about 4.1 days to cover all shorted shares.
Guardant Health reports about 853.69 M in cash with (324.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35.
Check Guardant Health Probability Of Bankruptcy
Ownership AllocationGuardant Health secures a total of 121.71 Million outstanding shares. The majority of Guardant Health outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Guardant Health to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Guardant Health. Please pay attention to any change in the institutional holdings of Guardant Health as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Guardant Ownership Details
Guardant Stock Price Odds Analysis
Coming from a normal probability distribution, the odds of Guardant Health jumping above the current price in 90 days from now is about 79.23%. The Guardant Health probability density function shows the probability of Guardant Health stock to fall within a particular range of prices over 90 days. Allowing for the 90-day total investment horizon the stock has a beta coefficient of 2.2478. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Guardant Health will likely underperform. Additionally, guardant Health has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Guardant Health to move above the current price in 90 days from now is about 79.23 (This Guardant Health probability density function shows the probability of Guardant Stock to fall within a particular range of prices over 90 days) .
Guardant Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Guardant Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Guardant Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Guardant Health's value.| Instituion | Recorded On | Shares | |
| Geode Capital Management, Llc | 2023-12-31 | 2.5 M | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 2.5 M | |
| Capital Research Global Investors | 2023-12-31 | 2.3 M | |
| Fidelity International Ltd | 2023-12-31 | 2 M | |
| T. Rowe Price Associates, Inc. | 2023-12-31 | 1.8 M | |
| Goldman Sachs Group Inc | 2023-12-31 | 1.8 M | |
| Credit Suisse First Boston (csfb) | 2023-12-31 | 1.8 M | |
| Clearbridge Advisors, Llc | 2023-12-31 | 1.5 M | |
| Franklin Resources Inc | 2023-12-31 | 1.4 M | |
| Vanguard Group Inc | 2023-12-31 | 11.1 M | |
| Blackrock Inc | 2023-12-31 | 10.8 M |
Guardant Health Historical Income Statement
Guardant Health Income Statement is one of the three primary financial statements used for reporting Guardant's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Guardant Health revenue and expense. Guardant Health Income Statement primarily focuses on the company's revenues and expenses during a particular period.
As of now, Guardant Health's Depreciation And Amortization is increasing as compared to previous years. The Guardant Health's current Interest Expense is estimated to increase to about 2.8 M, while Selling General Administrative is projected to decrease to under 118.7 M. View More FundamentalsGuardant Stock Against Markets
Picking the right benchmark for Guardant Health stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Guardant Health stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Guardant Health is critical whether you are bullish or bearish towards Guardant Health at a given time. Please also check how Guardant Health's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Guardant Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Guardant Health Corporate Directors
Guardant Health corporate directors refer to members of a Guardant Health board of directors. The board of directors generally takes responsibility for the Guardant Health's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Guardant Health's board members must vote for the resolution. The Guardant Health board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Ian Clark | Lead Independent Director | Profile | |
| Aaref Hilaly | Independent Director | Profile | |
| Dipchand Nishar | Independent Director | Profile | |
| Bahija Jallal | Director | Profile |
How to buy Guardant Stock?
Before investing in Guardant Health, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Guardant Health. To buy Guardant Health stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Guardant Health. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Guardant Health stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Guardant Health stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Guardant Health stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Guardant Health, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Guardant Stock please use our How to Invest in Guardant Health guide.
Already Invested in Guardant Health?
The danger of trading Guardant Health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Guardant Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Guardant Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Guardant Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Guardant Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardant Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardant Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardant Health Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.036 | Quarterly Revenue Growth 0.222 | Return On Assets (0.18) | Return On Equity (4.38) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.